Selim Syed, Managing Director at Mizuho, joins Worldwide Exchange to give his thoughts on why more than 20% of NASDAQ Biotech Index’s members are trading for less than cash, a figure than hasn’t existed in data since 2002.
You May Also Like
About the Author: Chaz Cutler
My name is Chasity. I love to follow the stock market and financial news!